Contact
Please use this form to send email to PR contact of this press release:
FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids
TO:
Please use this form to send email to PR contact of this press release:
FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids
TO: